Accessibility Menu
Visioneering Technologies Stock Quote

Visioneering Technologies (ASX: VTI)

Some price data may be temporarily unavailable.

KEY DATA POINTS

Current Price
N/A
Daily Change
N/A
Day's Range
N/A
Previous Close
N/A
Open
N/A
Beta
N/A
Volume
N/A
Average Volume
N/A
Market Cap
N/A
Market Cap / Employee
N/A
52wk Range
N/A
Revenue
N/A
Gross Margin
N/A
Dividend Yield
N/A
EPS
N/A
CAPs Rating
N/A
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Visioneering Technologies Company Info

Visioneering Technologies, Inc. is an eye care company, which engages in the design, manufacture, sale, and distribution of contact lenses. The firm focuses on the treatment of presbyopia in adults and myopia correction in children. The company's flagship product is NaturalVue, which is used in multifocal contact lenses for the treatment of myopia. It operates through the North America and Europe/Asia-Pacific geographic segments. The North America segment includes the firm's current operations in the U.S. and Canada. The Europe/Asia-Pacific segment refers to the operations outside of North America. The company was by Richard A. Griffin founded in 2008 and is headquartered in Alpharetta, GA.

News & Analysis

No results found

No news articles found for Visioneering Technologies.

No results found

No podcast episodes available.

No results found

No transcripts available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.